Principe du double effet : Questions médicales fréquentes
Nom anglais: Double Effect Principle
Descriptor UI:D034723
Tree Number:N05.350.238
Termes MeSH sélectionnés :
Extracellular Matrix
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Principe du double effet : Questions médicales les plus fréquentes",
"headline": "Principe du double effet : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Principe du double effet : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-24",
"dateModified": "2025-03-19",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Principe du double effet"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Éthique",
"url": "https://questionsmedicales.fr/mesh/D004989",
"about": {
"@type": "MedicalCondition",
"name": "Éthique",
"code": {
"@type": "MedicalCode",
"code": "D004989",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "N05.350"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Principe du double effet",
"alternateName": "Double Effect Principle",
"code": {
"@type": "MedicalCode",
"code": "D034723",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tao Zhang",
"url": "https://questionsmedicales.fr/author/Tao%20Zhang",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Shiyou Chen",
"url": "https://questionsmedicales.fr/author/Shiyou%20Chen",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Muhammad Faizan",
"url": "https://questionsmedicales.fr/author/Muhammad%20Faizan",
"affiliation": {
"@type": "Organization",
"name": "Department of Physics, University of Peshawar, Peshawar 25120, Pakistan. faizanstd@uop.edu.pk shkhan@uop.edu.pk."
}
},
{
"@type": "Person",
"name": "Jiahao Xie",
"url": "https://questionsmedicales.fr/author/Jiahao%20Xie",
"affiliation": {
"@type": "Organization",
"name": ""
}
},
{
"@type": "Person",
"name": "Ghulam Murtaza",
"url": "https://questionsmedicales.fr/author/Ghulam%20Murtaza",
"affiliation": {
"@type": "Organization",
"name": ""
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Intratympanic injection of MSC-derived small extracellular vesicles protects spiral ganglion neurons from degeneration.",
"datePublished": "2024-09-03",
"url": "https://questionsmedicales.fr/article/39232388",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.biopha.2024.117392"
}
},
{
"@type": "ScholarlyArticle",
"name": "Dysregulated neutrophil extracellular traps and haemostatic biomarkers as diagnostic tools and therapeutic targets in periprosthetic joint infection.",
"datePublished": "2024-09-01",
"url": "https://questionsmedicales.fr/article/39216868",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1302/0301-620X.106B9.BJJ-2024-0187.R1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Hydrogel encapsulation of mesenchymal stem cells-derived extracellular vesicles as a novel therapeutic approach in cancer therapy.",
"datePublished": "2024-08-30",
"url": "https://questionsmedicales.fr/article/39218403",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bbcan.2024.189177"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differentially expressed miRNA profiles of serum derived extracellular vesicles from patients with acute ischemic stroke.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39168264",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.brainres.2024.149171"
}
},
{
"@type": "ScholarlyArticle",
"name": "Induction of Ferroptosis by an Amalgam of Extracellular Vesicles and Iron Oxide Nanoparticles Overcomes Cisplatin Resistance in Lung Cancer.",
"datePublished": "2024-08-19",
"url": "https://questionsmedicales.fr/article/39229071",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1101/2024.08.19.608664"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Qualité, accès, évaluation des soins de santé",
"item": "https://questionsmedicales.fr/mesh/D017530"
},
{
"@type": "ListItem",
"position": 3,
"name": "Éthique",
"item": "https://questionsmedicales.fr/mesh/D004989"
},
{
"@type": "ListItem",
"position": 4,
"name": "Principe du double effet",
"item": "https://questionsmedicales.fr/mesh/D034723"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Principe du double effet - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Principe du double effet",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Principe du double effet",
"description": "Comment évaluer le besoin d'un traitement selon ce principe ?\nQuels critères déterminent l'application du double effet ?\nComment le double effet s'applique-t-il en oncologie ?\nQuelles sont les implications légales du double effet ?\nComment le double effet est-il perçu par les patients ?",
"url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Extracellular+Matrix&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Principe du double effet",
"description": "Quels symptômes peuvent justifier l'application du double effet ?\nComment évaluer la douleur en fin de vie ?\nQuels sont les effets secondaires possibles des traitements ?\nComment gérer l'anxiété en soins palliatifs ?\nQuels symptômes peuvent être aggravés par le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Extracellular+Matrix&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Principe du double effet",
"description": "Comment prévenir la douleur en soins palliatifs ?\nQuelles stratégies de communication sont efficaces ?\nComment impliquer la famille dans le processus ?\nQuels rôles jouent les soins palliatifs dans la prévention ?\nComment éduquer les patients sur le double effet ?",
"url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Extracellular+Matrix&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Principe du double effet",
"description": "Quels traitements sont souvent justifiés par le double effet ?\nComment choisir un traitement en respectant le double effet ?\nQuels médicaments sont couramment utilisés en soins palliatifs ?\nComment évaluer l'efficacité d'un traitement ?\nQuels sont les risques d'une sédation profonde ?",
"url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Extracellular+Matrix&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Principe du double effet",
"description": "Quelles complications peuvent survenir avec le double effet ?\nComment gérer les complications des traitements ?\nQuels sont les dilemmes éthiques associés ?\nComment prévenir les malentendus sur le double effet ?\nQuels impacts psychologiques peuvent résulter du double effet ?",
"url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Extracellular+Matrix&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Principe du double effet",
"description": "Quels facteurs augmentent le besoin de soins palliatifs ?\nComment l'âge influence-t-il le principe du double effet ?\nQuels rôles jouent les croyances culturelles ?\nComment les antécédents médicaux affectent-ils le traitement ?\nQuels facteurs psychologiques influencent le traitement ?",
"url": "https://questionsmedicales.fr/mesh/D034723?mesh_terms=Extracellular+Matrix&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer le besoin d'un traitement selon ce principe ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer les bénéfices et les risques du traitement pour le patient en fin de vie."
}
},
{
"@type": "Question",
"name": "Quels critères déterminent l'application du double effet ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les critères incluent l'intention, la proportionnalité et la distinction entre effets."
}
},
{
"@type": "Question",
"name": "Comment le double effet s'applique-t-il en oncologie ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est souvent utilisé pour justifier l'analgésie dans le traitement de la douleur cancéreuse."
}
},
{
"@type": "Question",
"name": "Quelles sont les implications légales du double effet ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les implications varient selon les juridictions, mais il peut protéger les médecins d'accusations."
}
},
{
"@type": "Question",
"name": "Comment le double effet est-il perçu par les patients ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les perceptions varient, certains acceptent l'idée, d'autres craignent l'euthanasie déguisée."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent justifier l'application du double effet ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes intenses comme la douleur, l'anxiété ou la dyspnée peuvent justifier son application."
}
},
{
"@type": "Question",
"name": "Comment évaluer la douleur en fin de vie ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des échelles de douleur pour évaluer l'intensité et adapter le traitement."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires possibles des traitements ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure sédation, nausées ou dépression respiratoire."
}
},
{
"@type": "Question",
"name": "Comment gérer l'anxiété en soins palliatifs ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des anxiolytiques ou des thérapies non médicamenteuses pour soulager l'anxiété."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent être aggravés par le traitement ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme la confusion ou la fatigue peuvent être exacerbés par certains traitements."
}
},
{
"@type": "Question",
"name": "Comment prévenir la douleur en soins palliatifs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Anticiper les besoins en analgésie et éduquer le patient sur la gestion de la douleur."
}
},
{
"@type": "Question",
"name": "Quelles stratégies de communication sont efficaces ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser une communication claire et empathique pour discuter des traitements et des effets."
}
},
{
"@type": "Question",
"name": "Comment impliquer la famille dans le processus ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Impliquer la famille dans les décisions de traitement pour assurer un soutien adéquat."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les soins palliatifs dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les soins palliatifs visent à prévenir la souffrance et à améliorer la qualité de vie."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur le double effet ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fournir des informations claires sur le principe et ses implications pour les décisions de traitement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont souvent justifiés par le double effet ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements analgésiques, sédatifs et certains traitements palliatifs sont souvent justifiés."
}
},
{
"@type": "Question",
"name": "Comment choisir un traitement en respectant le double effet ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisir un traitement qui maximise le bénéfice tout en minimisant les effets indésirables."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont couramment utilisés en soins palliatifs ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les opioïdes, les benzodiazépines et les anti-inflammatoires sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un traitement ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Évaluer régulièrement les symptômes et ajuster le traitement en fonction des résultats."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une sédation profonde ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent la dépression respiratoire et la perte de conscience prolongée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec le double effet ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des effets indésirables graves et des malentendus éthiques."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des traitements ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller attentivement les effets secondaires et ajuster le traitement si nécessaire."
}
},
{
"@type": "Question",
"name": "Quels sont les dilemmes éthiques associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dilemmes incluent la distinction entre intention et effet, et la responsabilité du médecin."
}
},
{
"@type": "Question",
"name": "Comment prévenir les malentendus sur le double effet ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éduquer les patients et les familles sur le principe pour éviter les malentendus."
}
},
{
"@type": "Question",
"name": "Quels impacts psychologiques peuvent résulter du double effet ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les impacts peuvent inclure la culpabilité chez les soignants et l'anxiété chez les patients."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le besoin de soins palliatifs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les maladies avancées, la douleur chronique et les comorbidités augmentent ce besoin."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le principe du double effet ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les patients âgés peuvent avoir des besoins spécifiques en matière de gestion de la douleur."
}
},
{
"@type": "Question",
"name": "Quels rôles jouent les croyances culturelles ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les croyances culturelles peuvent influencer les décisions concernant les traitements et la douleur."
}
},
{
"@type": "Question",
"name": "Comment les antécédents médicaux affectent-ils le traitement ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux peuvent influencer la tolérance aux traitements et les effets secondaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs psychologiques influencent le traitement ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'anxiété, la dépression et le soutien social peuvent influencer l'acceptation des traitements."
}
}
]
}
]
}
Sensorineural hearing loss is one of the most prevalent sensory deficits. Spiral ganglion neurons (SGNs) exhibit very limited regeneration capacity and their degeneration leads to profound hearing los...
Bacterial infection activates neutrophils to release neutrophil extracellular traps (NETs) in bacterial biofilms of periprosthetic joint infections (PJIs). The aim of this study was to evaluate the in...
We prospectively recruited 107 patients in the preoperative period of prosthetic surgery, 71 with a suspicion of PJI and 36 who underwent arthroplasty for non-septic indications as controls, and obtai...
Patients with confirmed PJI had significantly increased levels of NET markers (cfDNA (p < 0.001), calprotectin (p < 0.001), and neutrophil elastase (p = 0.022)) and inflammation markers (IL-6; p < 0.0...
We confirmed that patients with PJI have an increased level of NETosis in plasma. Their plasma both induced NET release and had an impaired ability to degrade NETs mediated by a reduced DNaseI activit...
Cell therapy has emerged as one of the most promising approaches to treating disease in recent decades. The application of stem cells in anti-tumor therapy is determined by their varying capacity for ...
MicroRNAs (miRNAs) participate in diverse cellular changes following acute ischemic stroke (AIS). Circulating miRNAs, stabilized and delivered to target cells via extracellular vesicles (EVs), are pot...
miRNA profiles from EVs, isolated from plasma samples collected within 24 h following AIS diagnosis, were examined between a dataset of 10 age-, gender- and existing comorbidities-matched subjects (5 ...
Five miRNAs were differentially expressed between stroke (AIS) versus control (HC). hsa-let-7b-5p, hsa-miR-16-5p, and hsa-miR-320c were upregulated, whereas hsa-miR-548a-3p and hsa-miR-6808-3p, with n...
Our findings reveal distinct circulating EV-miRNA expression patterns in AIS patients from Qatar, highlighting potential biomarkers that could aid in stroke diagnosis and therapeutic strategies. The i...
Extracellular vesicles (EVs) hold potential as effective carriers for drug delivery, providing a promising approach to resolving challenges in lung cancer treatment. Traditional treatments, such as wi...
Although conventional intervention to microglia can mitigate neuroinflammation in the short term, immune disorders by peripheral inflammatory cells can infiltrate continuously, resulting in an overact...
Rheumatoid arthritis (RA) is a chronic systemic autoimmune disease. Abnormal formation of neutrophil extracellular traps (NETs) at the synovial membrane leads to the release of many inflammatory cytok...
We sought to determine neutrophil extracellular trap (NET)-related genes' potential value in improving the efficacy of diagnosis and identifying novel therapeutic targets for osteosarcoma. Data were o...
Ischemic stroke is a secondary cause of mortality worldwide, imposing considerable medical and economic burdens on society. Extracellular vesicles, serving as natural nano-carriers for drug delivery, ...
Immune escape is the main reason that immunotherapy is ineffective in hepatocellular carcinoma (HCC). Here, this study illustrates a pathway mediated by neutrophil extracellular traps (NETs) that can ...